Ovarian cancer: interplay of vitamin D signaling and miRNA action.

作者: Rukset Attar , Maria Luisa Gasparri , Violante Di Donato , Ilhan Yaylim , Talha Abdul Halim

DOI: 10.7314/APJCP.2014.15.8.3359

关键词:

摘要: Increasing attention is being devoted to the mechanisms by which cells receive signals and then translate these into decisions for growth, death, or migration. Recent findings have presented significant breakthroughs in developing a deeper understanding of activation repression target genes proteins response various stimuli how they are assembled during signal transduction cancer cells. Detailed mechanistic insights unveiled new maps linear integrated cascades, but multifaceted nature pathways remains unclear. Although layers information added regarding underlying ovarian polymorphisms VDR gene influence its development, this research must be sequentially collected re-interpreted. We divide multi-component review different segments: vitamin D modulates molecular network cells, controlled tumor suppressors oncogenic miRNAs finally signaling regulates miRNA expression. Intra/inter-population variability insufficiently studied better genetics population will helpful getting step closer personalized medicine.

参考文章(30)
Zheng Shen, Xiaohui Zhang, Jinfu Tang, Ravi Kasiappan, Umesh Jinwal, Pengfei Li, Shan Hann, Santo V. Nicosia, Jie Wu, Xiaohong Zhang, Wenlong Bai, The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells Molecular and Cellular Endocrinology. ,vol. 338, pp. 58- 67 ,(2011) , 10.1016/J.MCE.2011.02.023
Lu Yin, Norma Grandi, Elke Raum, Ulrike Haug, Volker Arndt, Hermann Brenner, Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecologic Oncology. ,vol. 121, pp. 369- 375 ,(2011) , 10.1016/J.YGYNO.2011.01.023
J Cai, C Yang, Q Yang, H Ding, J Jia, J Guo, J Wang, Z Wang, Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin Oncogenesis. ,vol. 2, ,(2013) , 10.1038/ONCSIS.2013.39
Yuqi Guo, Peng Tian, Chuanhe Yang, Zhibing Liang, Min Li, Michelle Sims, Lu Lu, Zhan Zhang, Hongwei Li, Lawrence M. Pfeffer, Junming Yue, Silencing the Double-Stranded RNA Binding Protein DGCR8 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Pharmaceutical Research. ,vol. 32, pp. 769- 778 ,(2015) , 10.1007/S11095-013-1219-9
Ting Ji, Zhi-Guo Zheng, Feng-Mei Wang, Li-Jian Xu, Lu-Feng Li, Qi-Hui Cheng, Jiang-Feng Guo, Xian-Feng Ding, Differential microRNA Expression by Solexa Sequencing in the Sera of Ovarian Cancer Patients Asian Pacific Journal of Cancer Prevention. ,vol. 15, pp. 1739- 1743 ,(2014) , 10.7314/APJCP.2014.15.4.1739
Yan Zhang, Sheng-Chun Tong, Li-Hua Guan, Fei Na, Wei Zhao, Li Wei, None, Meta-analysis of the relation between vitamin D receptor gene BsmI polymorphism and susceptibility to ovarian cancer Tumor Biology. ,vol. 34, pp. 3317- 3321 ,(2013) , 10.1007/S13277-013-0900-2
YAN KUANG, JING CAI, DONGLIN LI, QIN HAN, JIN CAO, ZEHUA WANG, Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer. Oncology Letters. ,vol. 5, pp. 1149- 1154 ,(2013) , 10.3892/OL.2013.1158
ZHONGXIAN WANG, ZHOU TING, YA LI, GANG CHEN, YUNPING LU, XING HAO, microRNA‑199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin Oncology Letters. ,vol. 6, pp. 789- 794 ,(2013) , 10.3892/OL.2013.1448